M&A London M&A Calling — Mergers & Acquisitions
There are signs of recovery in mid-market M&A in the U.K. and Continental Europe, creating a list of potential takeover targets to watch in 2024.
Source: themiddlemarket.com
📰 Life Sciences Partners News
Life Sciences Partners News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Life Sciences Partners. Real-time updates on events, politics, business and more.
Governor, local officials join in groundbreaking for OneNKY Center, another William Butler 'vision' - NKyTribune
By Judy ClabesNKyTribune editorMore than 30 years after the first groundbreaking for what has become the RiverCenter complex on Covington's riverfront, there was a groundbreaking celebration Wed
Source: nkytribune.com
Galway medtech company tackling runny noses raises almost €10m
Neurent Medical, a Galway company developing a device to alleviate runny noses, has raised almost €10 million.The medtech firm, set up in 2015, has raised fund
Source: thetimes.co.uk
Covington Life Sciences Partners announces new research and development lab at OneNKY Center
Covington Life Sciences Partners, Inc. (CLSP), a non-profit corporation established in November 2022, was founded to advance science, education, entrepreneurism, and job creation in the Northern Kentu
United States Commonwealth Of Kentucky Northern Kentucky University City Of Covington Dinesh Ganapathy Garren Colvin
Source: nkytribune.com
EQT AB (publ) Year-end Report 2022
/PRNewswire/ -- "EQT concluded 2022 – a transformative year – as a global leader in active ownership. We relentlessly continue to future-proof our expanding...
Source: prnewswire.com
Private Equity Acquires A Taste For Drug Development
Private equity firms that deemed drug development too risky for their liking in the past are increasingly investing in the sector, raising dedicated funds and coming up with deals that compensate
Nick Galakatos Tom Davidson Blackstone Inc Alnylam Pharmaceuticals Inc Apollo Global Management Inc Partners Inc
Source: ibtimes.com
Private equity acquires a taste for drug development
By David Carnevali (Reuters) - Private equity firms that deemed drug development too risky for their liking in the past are increasingly investing in ...
Source: whbl.com
EQT AB (publ): Half-year Report 2022 (1)
STOCKHOLM, July 14, 2022 /PRNewswire/ -- "The war in Ukraine has accelerated the slow down in the global...
Source: europapress.es
EQT AB (publ): Half-year Report 2022 (2)
STOCKHOLM, July 14, 2022 /PRNewswire/ -- "The war in Ukraine has accelerated the slow down in the global...
Edith Cooper Alexandra Lutz Christian Sinding Christina Drews V Lennart Blecher Infrastructure Advisory Team
Source: europapress.es